Literature DB >> 26545833

Rethinking traditional Chinese medicines for cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26545833     DOI： 10.1016/S1470-2045(15)00406-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  10 in total

1.  Combination of Chinese and Western Medicine to Prevent and Reverse Resistance of Cancer Cells to Anticancer Drugs.

Authors:  Xin-Bing Sui; Tian Xie
Journal:  Chin J Integr Med       Date:  2019-11-09       Impact factor: 1.978

2.  Hyperin Controls the Development and Therapy of Gastric Cancer via Regulating Wnt/β-Catenin Signaling.

Authors:  Mao-Hua Ping
Journal:  Cancer Manag Res       Date:  2020-11-17       Impact factor: 3.989

Review 3.  Immunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Yang Yang; Wang Ting; Liu Xiao; Fu Shufei; Tan Wangxiao; Wang Xiaoying; Gao Xiumei; Zhang Boli
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-05       Impact factor: 2.629

4.  Anti-Tumor Activity of Cembranoid-Type Diterpenes Isolated from Nicotiana tabacum L.

Authors:  Xiao-Long Yuan; Xin-Xin Mao; Yong-Mei Du; Pei-Zhen Yan; Xiao-Dong Hou; Zhong-Feng Zhang
Journal:  Biomolecules       Date:  2019-01-28

5.  Literature Review of Traditional Chinese Medicine Herbs-Induced Liver Injury From an Oncological Perspective With RUCAM.

Authors:  Hei Ching Chow; Tsz Him So; Horace Cheuk Wai Choi; Ka On Lam
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

6.  Huaier polysaccharide inhibits the stem-like characteristics of ERα-36high triple negative breast cancer cells via inactivation of the ERα-36 signaling pathway.

Authors:  Baoquan Hu; Wenting Yan; Minghao Wang; Xiang Cui; Ying Hu; Qingqiu Chen; Yi Zhang; Xiaowei Qi; Jun Jiang
Journal:  Int J Biol Sci       Date:  2019-05-20       Impact factor: 6.580

7.  Effects and safety of herbal medicines among community-dwelling residents during COVID-19 pandemic: A large prospective, randomized controlled trial (RCT).

Authors:  Bohua Yan; Zhiwei Jiang; Jing Yuan; Minghui Li; Jieping Zeng; Jianyuan Tang; Z Kevin Lu; Hong Ding; Jielai Xia; Qiaoling Wang; Jundong Wang; Hongyan Xie; Wenyuan Li; Na Zhang; Haiyan Li; Xiaoya Sang; Lina Wu; Xiaomo Xiong; Shiyun Tang; Yan Li; Mengyao Tao; Chunguang Xie; Shuguang Yu
Journal:  Phytomedicine       Date:  2020-11-05       Impact factor: 5.340

8.  Columbamine-Mediated PTEN/AKT Signal Pathway Regulates the Progression of Glioma.

Authors:  Hai-Tao Niu; Yang Liu; Yan-Zhou Wang; Yong Tian; Ming Yang; Hong-Sheng Jiang
Journal:  Cancer Manag Res       Date:  2021-01-19       Impact factor: 3.989

9.  Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series.

Authors:  Bin Luo; Ming Yang; Zixin Han; Zujun Que; Tianle Luo; Jianhui Tian
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

10.  Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme.

Authors:  Ji Wu; Xue-Yu Li; Jing Liang; Da-Lang Fang; Zhao-Jian Yang; Jie Wei; Zhi-Jun Chen
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.